XPACPriority claimed from 30/08/2021; Application No. : 97002544 ;United States of America (Class 1)
#5348300
Application Number:5348300
Status:
Unknown
Class:1
Applicant: Amunix Pharmaceuticals, Inc.
Filing Date:Mon, 28 Feb 2022
Get a free email alert the moment this application's status changes.
Trademark Information
| Trademark | XPACPriority claimed from 30/08/2021; Application No. : 97002544 ;United States of America |
| Trademark Type | Wordmark |
| Class | 1 |
| Application Number | 5348300 |
| Nature/Scope of business | hemicals used in the manufacture of pharmaceuticals; reagents, enzymes, and nucleotides for scientific or medical research; protein polymeric intermediates for use in the manufacture of pharmaceutical preparations; biomedical compounds, namely, peptides, peptidomimetics, and protein polymeric intermediates used in the manufacture of pharmaceutical preparations. |
| Publication | In Journal No. 2144 |
| Status | Unknown |
| Applicant: | Amunix Pharmaceuticals, Inc. |
| Applicant Address | 2 Tower Pl, #1100 South San Francisco, California 94080 A Delaware Corporation |
| Jurisdiction | DELHI |
| Agent | RNA, IP ATTORNEYS |
| Agent Address | 401-402, 4TH FLOOR, SUNCITY SUCCESS TOWER, SEC-65, GOLF COURSE EXTENSION ROAD, GURGAON-122005 NATIONAL CAPITAL REGION (HARYANA) |
Frequently Asked Questions
Who is the owner of trademark XPACPriority claimed from 30/08/2021; Application No. : 97002544 ;United States of America? ▾
The trademark application number 5348300 is owned by Amunix Pharmaceuticals, Inc..
Which class does trademark XPACPriority claimed from 30/08/2021; Application No. : 97002544 ;United States of America belong to? ▾
Trademark application number 5348300 is filed under Class 1, which relates to the specified goods and services.
Who is the trademark agent for application 5348300? ▾
The trademark agent associated with application number 5348300 is RNA, IP ATTORNEYS.
Was trademark XPACPriority claimed from 30/08/2021; Application No. : 97002544 ;United States of America published in the journal? ▾
Yes, trademark application number 5348300 was published in Journal No. 2144.
What is trademark XPACPriority claimed from 30/08/2021; Application No. : 97002544 ;United States of America? ▾
Trademark application number 5348300 relates to "hemicals used in the manufacture of pharmaceuticals; reagents, enzymes, and nucleotides for scientific or medical research; protein polymeric intermediates for use in the manufacture of pharmaceutical preparations; biomedical compounds, namely, peptides, peptidomimetics, and protein polymeric intermediates used in the manufacture of pharmaceutical preparations.".
File Trademark at Just ₹1,499 + Govt Fees
Get your trademark registered with expert guidance. Limited time offer!
File NowExpert Consultation
Quick Processing
100% Support
Free Report
Get Detailed Trademark Report
Comprehensive analysis of your trademark search delivered to your phone
What you'll get:
- Complete trademark analysis
- Conflict assessment
- Registration guidance
15,000+Trademarks Filed
98%Success Rate
Govt Authorized
ISO Certified